Gilead Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Gilead Sciences generated cash of $11,384,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$8,877,000,000 last year. Net change in cash is therefore -$659,000,000.
Cash Flow
| 2012 | 3.19B | -11.84B | 563.34M |
|---|---|---|---|
| 2013 | 3.10B | -254.35M | -2.54B |
| 2014 | 12.81B | -1.82B | -3.02B |
| 2015 | 20.32B | -12.47B | -4.96B |
| 2016 | 16.66B | -11.98B | -9.34B |
| 2017 | 11.89B | -16.06B | 3.39B |
| 2018 | 8.4B | 14.35B | -12.31B |
| 2019 | 9.14B | -7.81B | -7.63B |
| 2020 | 8.16B | -14.61B | 770M |
| 2021 | 11.38B | -3.13B | -8.87B |
GILD.SW Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.99B | 11.63B | 17.94B | 7.58B | 8.22B | 12.85B | 10.02B | 2.11B | 1.80B | 9.88B |
Operating activities | ||||||||||
Net income | 6.22B | 123M | 5.38B | 5.45B | 4.62B | 13.50B | 18.10B | 12.10B | 3.07B | 2.59B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 1.48B | 1.40B | 1.42B | 1.28B | 1.15B | 1.09B | 1.05B | 344.70M | 278.20M |
Stock-based compensation expense | 0 | 643M | 636M | 845M | 638M | 380M | 382M | 360M | 251.98M | 208.72M |
| Deferred income tax benefit | 0 | 643M | 636M | 845M | 638M | 380M | 382M | 360M | 251.98M | 208.72M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -1.17B | -218M | 480M | 754M | 1.19B | -1.39B | -2.57B | -315.29M | 197.98M |
Inventories | 0 | -195M | -95M | -310M | -253M | -488M | -855M | 143M | -343.14M | -349.92M |
Accounts payable | 0 | 80M | -61M | -39M | -430M | 47M | 226M | -289M | -97.67M | 117.48M |
Cash generated by operating activities | 11.38B | 8.16B | 9.14B | 8.4B | 11.89B | 16.66B | 20.32B | 12.81B | 3.10B | 3.19B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -20.77B | -32.22B | -10.57B | -23.31B | -25.97B | -17.23B | -2.12B | -256.7M | -1.26B |
Investments In Property Plant And Equipment | 0 | -650M | -825M | -924M | -590M | -748M | -747M | -557M | -190.78M | 0 |
Acquisitions Net | 0 | -25.74B | 825M | 924M | -10.42B | 748M | 747M | 557M | -378.64M | -10.75B |
Cash generated by investing activities | -3.13B | -14.61B | -7.81B | 14.35B | -16.06B | -11.98B | -12.47B | -1.82B | -254.35M | -11.84B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 256M | 209M | 289M | 234M | 208M | 319M | 331M | 313.07M | 466.28M |
Payments for dividends | 0 | -3.44B | -3.22B | -2.97B | -2.73B | -2.45B | -1.87B | 0 | 0 | 0 |
Repurchases of common stock | 0 | -1.58B | -1.74B | -2.9B | -954M | -11.00B | -10.00B | -5.34B | -582.35M | -667.04M |
Repayments of term debt | 0 | -2.5B | 0 | -6.25B | 0 | -1.98B | 0 | -4.80B | -4.43B | -1.83B |
Cash used in financing activities | -8.87B | 770M | -7.63B | -12.31B | 3.39B | -9.34B | -4.96B | -3.02B | -2.54B | 563.34M |
Net Change In Cash | -659M | -5.63B | -6.30B | 10.35B | -641M | -4.62B | 2.82B | 7.91B | 309.11M | -8.08B |
Cash at end of period | 5.33B | 5.99B | 11.63B | 17.94B | 7.58B | 8.22B | 12.85B | 10.02B | 2.11B | 1.80B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |